Please login to your online account to display your discounted pricing

anti-Androgen R/NR3C4 (p Ser213, p Ser210), Clone: 156C135.2, Novus Biologicals™


Manufacturer: novus biologicals canada  NB10056603SS

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NB10056603T

  • / Each
 

Description & Specifications

Specifications

Immunogen This antibody was developed against a synthetic peptide corresponding to amino acids 207-221 (GRAREAS*GAPTSSKD) of human androgen receptor, containing the serine 213 phosphorylation site: GenBank Accession No. A39248. Note: S* refers to phosphorylated serine in the peptide sequence.
Monoclonal or Polyclonal Monoclonal
Gene ID (Entrez) 367
Formulation 0.2mL PBS containing 0.05% BSA
Gene Accession No. P10275
Primary or Secondary Primary
Conjugate Unlabeled
Test Specificity In IGF-1 stimulated LNCaP cells (passage number 38), a ∽110 kDa band was observed. Please see Lin et al. 2003 for additional details. The serine phosphorylation site recognized by this antibody has been alternatively referred to Ser213 (Lee and Chang, 2003) and Ser210 (Lin et al, 2003). Variations in denotation can arise from how the sequence is counted in various GenBank accession numbers. The site is denoted as Ser213 in GenBank Accession No. A39248, which was used to design the immunogen. Human and New World Monkey. Predicted cross-reactivity with Chimpanzee, Dog, Mouse, Pig and Rat.
Concentration 0.5mg/mL
Host Species Mouse
Applications Immunohistochemistry
Applications Immunohistochemistry (Paraffin)
Applications Western Blotting
Antigen Androgen R/NR3C4 (p Ser213
Isotype κ
Cross Reactivity Human
Cross Reactivity Primate
Quantity 0.025mg
Regulatory Status RUO
Format Purified
Clone 156C135.2